Affimed NV
SWB:A28
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Affimed NV
SWB:A28
|
DE |
|
R
|
Rex Resources Corp
XTSX:OWN
|
CA |
|
D
|
Dawood Equities Ltd
KAR:DEL
|
PK |
|
N
|
National Asset Recovery Corp
OTC:REPO
|
US |
|
N
|
NPC Inc
F:59N
|
JP |
|
P
|
Prospect Park Capital Corp
CNSX:PPK
|
CA |
|
Range International Ltd
ASX:RAN
|
AU |
|
H
|
HawkEye 360 Inc
NYSE:HAWK
|
US |
|
S
|
Scient Inc
OTC:SCNTQ
|
US |
|
West Bancorporation Inc
NASDAQ:WTBA
|
US |
|
C
|
Celxpert Energy Corp
TPEX:3323
|
TW |
|
C
|
Compodium International AB (publ)
STO:COMPDM
|
SE |
|
A
|
Alignvest Acquisition II Corp
OTC:SGCFF
|
CA |
|
A
|
Arcadia Biosciences Inc
F:17DN
|
US |
|
OncoTherapy Science Inc
TSE:4564
|
JP |
|
Pancontinental Energy NL
OTC:PCOGF
|
AU |
|
N
|
Ningbo Tip Rubber Technology Co Ltd
SSE:605255
|
CN |
|
Star Phoenix Group Ltd
LSE:STA
|
AU |
Bankruptcy Probability
Affimed NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Affimed NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Affimed NV
NASDAQ:AFMD
|
750k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Affimed NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Affimed NV has total debt of 6m EUR. This includes both short-term (0 EUR) and long-term (6m EUR) debt.
You can find a full breakdown on its Balance Sheet.
